Free Radical Research Center

Print Page Print   EmailEmail   Bookmark Page Bookmark   RSS Feeds RSS

2006 Publications for the Free Radical Research Center

  1. Liu Y, Bubolz AH, Shi Y, Newman PJ, Newman DK, Gutterman DD.  Peroxynitrite reduces the endothelium-derived hyperpolarizing factor component of coronary flow-mediated dilation in PECAM-1-knockout mice. Am J Physiol Regul Integr Comp Physiol. 2006 Jan;290(1):R57-65. See the Abstract 
     
  2. Periyannan GR, Costello AL, Tierney DL, Yang K-W, Bennett B, Crowder MW.  Sequential Binding of Cobalt(II) to Metallo-beta-lactamase CcrA. Biochemistry ASAP:10.1021/bi051105n, 2006.
     
  3. Nguyen TK, Nilakantan V, Felix CC, Khanna AK, Pieper GM.  Beneficial effect of alpha-tocopheryl succinate in rat cardiac transplants. J. Heart Lung Transplant. 25:707-715, 2006.
     
  4. Chahdi A, Sorokin A. Endothelin-1 stimulates b1Pix-dependent activation of Cdc42 through Gas-pathway. Exp. Biol. Med. 231:761-765, 2006. 
     
  5. Rufanova V, Sorokin A. CrkII Associates with BCAR3 in Response to Endothelin-1 in Human Glomerular Mesangial Cells. Exp. Biol. Med. 231:752-761, 2006
     
  6. Miller B, Patel V, Sorokin A. COX-2 rescues rat mesangial cells from apoptosis induced by adriamycin via upregulation of MDR1 (P-glycoprotein). J Am Soc Nephrol. 17:977-985, 2006
     
  7. Huh J, Liepins A, Zielonka J, Andrekopoulos C, Kalyanaraman B, Sorokin A. Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine induced apoptosis by mechanism involving inhibition of nitric oxide synthase activity. Cancer Research, 66:3726-3736, 2006
     
  8. Davies NP, Rahmanto S, Chitambar CR, Richardson DR. Resistance to gallium results in marked alterations in intracellular iron and gallium trafficking: Identification of novel intermediates Journal of Pharmacology and Experimental Therapeutics. 317:163-172, 2006.
     
  9. Chitambar CR, Kotamraju S, Wereley JP. Expression of the Hemochromatosis Gene (HFE) Modulates the Cytotoxicity of Doxorubicin in Breast Cancer Cells. International Journal of Cancer 119:2200-2204, 2006. 
     
  10. Chitambar CR, Wereley JP, Matsuyama S.  Gallium-induced cell death in lymphoma: role of transferrin receptor cycling, involvement of Bax and the mitochondria, and effects of proteasome inhibition. Molecular Cancer Therapeutics. 5:2834-2843, 2006.
     
  11. Nguyen TK, Nilakantan V, Felix CC, Khanna AK, Pieper GM. Benefits of -tocopheryl succinate in rat cardiac transplants. J. Heart Lung Transplant. 25:707-715, 2006.
     
  12. Falati S, Patil S, Gross PL, Stapleton M, Merrill-Skoloff G, Barrett NE, Pixton KL, Weiler H, Cooley B,  Newman DK, Newman PJ, Furie BC, Furie B, Gibbins JM. 2006. Platelet PECAM-1 inhibits thrombus formation in vivo. Blood 107:535-41. 
     
  13. Novinska MS, Rathore V, Newman DK, Newman PJ. PECAM-1. In Platelets (A. Michelson, editor), Academic Press, San Diego, CA 2006. 
     
  14. Novinska MS, Pietz BC, Ellis TM, Newman DK, Newman PJ. 2006. The alleles of PECAM-1. Gene 376:95-101. 
     
  15. Bergom C, Goel R, Paddock C, Gao C, Newman DK, Matsuyama S, Newman PJ. 2006. The cell-adhesion and signaling molecule PECAM-1 is a molecular mediator of resistance to genotoxic chemotherapy. Cancer Biology and Therapy 5:1699-707.
     
  16. Nilakantan V, Zhou X, Hilton G, Shi Y, Baker JE, Khanna AK, Pieper GM. Antagonizing reactive oxygen by treatment with a manganese (III) metalloporphyrin-based superoxide dismutase mimetic in cardiac transplants. J Thorac Cardiovasc Surg 131:898-906; 2006
     
  17. Kwitek AE, Jacob HJ, Baker JE, Dwinell MR, Forster HV, Greene AS, Kunert MP, Lombard JH, Mattson DL, Pritchard Jr KA, Roman RJ, Tonellato PJ, Cowley Jr AW. The BN phenome: Detailed characterization of the cardiovascular, renal and pulmonary systems of the sequenced rat. Physiol Genomics 25:202213; 2006
     
  18. Cabigas BP, Su J, Hutchins W, Shi Y, Schaefer RB, Recinos RF, Nilakantan V, Kindwall E, Niezgoda JA, Baker JE. Hyperoxic and hyperbaric-induced cardioprotection: role of nitric oxide synthase 3. Cardiovasc Res 72:143-51, 2006
     
  19. Tang X, Homes BB, Nithipatikom K, Hillard CJ, Kuhn H, Campbell WB. Reticulocyte 15-lipoxygenase-I is important in acetylcholine-induced endothelium-dependent vasorelaxation in rabbit aorta. Arterioscler. Thromb. Vasc. Biol. 26:78-84, 2006. 
     
  20. Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler H. Feto-maternal cross-talk in the placental vascular bed: control of coagulation by trophoblast cells. Blood 107:3173-3180, 2006.
     
  21. Patel S, Hillard CJ.  Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 318:304-311, 2006.
     
  22. Carrier EJ, Auchampach JA, Hillard CJ. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a novel mechanism of cannabinoid immunosuppression. Proc Natl. Acad. Sci. U.S.A. 103: 7895-900. 2006.
     
  23. Hill MN, Ho W-S V, Sinopoli K, Viau V, Hillard CJ, Gorzalka BB. Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacol. 31:2591-2599, 2006.
     
  24. Jurva JW, Phillips SA, Syed AQ, Syed AY, Pitt S, Weaver A, Gutterman DD. The Effect of Exertional Hypertension Evoked by Weightlifting on Vascular Endothelial Function. J.Am.Coll.Cardiol. 48:588-9, 2006.
     
  25. Hatoum OA, Otterson MF, Kopelman D, Miura H, Suktotnik I, Larsen B, Selle RM, Moulder JE, Gutterman DD. Radiation induces endothelial dysfunction in murine intestinal arterioles via enhanced production of reactive oxygen species. Arterioscler. Thromb. Vasc. Biol. 26(2): 287-94, 2006.
     
  26. Guyatt G, Gutterman DD, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Schünemann H. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 129: 174-181, 2006.
     
  27. Guyatt G, Baumann M, Pauker S, Halperin J, Maurer J, Owens DK, Tosteson ANA, Carlin B, Gutterman DD, Prins M, Lewis SZ, Schünemann H. Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. Chest 129: 182-187, 2006.
     
  28. Dhanasekaran A, Al-Saghir R, Lopez B, Zhu D, Gutterman DD, Jacobs ER, Medhora M. Protective Effects of Epoxyeicosatrienoic Acids (EETs) on Human Endothelial Cells from the Pulmonary and Coronary Vasculature. Am. J. Physiol. Heart Circ. Physiol. 291:H517-531, 2006
     
  29. Dedkov EI, Perloff JK, Tomanek RJ, Fishbein MC, Gutterman DD. The coronary microcirculation in cyanotic congenital heart disease. Circulation 114(3): 196-200, 2006.
     
  30. Larsen BT, Miura H, Hatoum OA, Campbell WB, Hammock BD, Zeldin DC, Falck JR, Gutterman DD. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BKCa channels: implications for soluble epoxide hydrolase inhibition. Amer. J. Physiol Heart Circ. Physiol. 290(2): H491-9, 2006.
webmaster@mcw.edu
© 2007 Medical College of Wisconsin
Page Updated 05/05/2008